The effects of reference pricing and other drug pricing policies

Morten Aaserud, Astrid A. Dahlgren, Jan Peter Kosters, Heidrun Strum, Craig R Ramsay, Andrew D. Oxman

Research output: Contribution to journalArticlepeer-review


We carried out a systematic review on studies of effects of pharmaceutical pricing policies. Ten studies of reference pricing and one study of index pricing were included. Based on the evidence in this review, mostly from senior citizens in British Columbia, Canada, reference drug pricing can reduce third party drug expenditures by inducing a shift in drug use towards less expensive drugs. We found no evidence of adverse effects on health and no clear evidence of increased health care utilisation.
Original languageEnglish
Pages (from-to)2-8
Number of pages7
JournalRegulatory Rapporteur
Issue number10
Publication statusPublished - Oct 2006


  • pharmaceutical policies
  • drug pricing
  • reference pricing


Dive into the research topics of 'The effects of reference pricing and other drug pricing policies'. Together they form a unique fingerprint.

Cite this